Transplanting retinal tissue to improve vision in models of eye disease
Retinal sheet transplant impact on functional organization of visual cortex in retinal degenerate animal models
This study is exploring whether transplanting special tissue sheets into the eyes of animals with serious vision loss from conditions like age-related macular degeneration and retinitis pigmentosa can help improve their sight by working better with the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11081660 on NIH RePORTER |
What this research studies
This research investigates the potential of transplanting retinal progenitor tissue sheets into the eyes of animal models suffering from severe vision loss due to age-related macular degeneration and retinitis pigmentosa. The approach aims to restore visual function by integrating these transplanted tissues into the existing retinal structure, allowing for improved visual processing in the brain. By studying the responses of the visual cortex to these transplants, researchers hope to understand how well the new tissue can communicate with the brain and enhance visual behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals suffering from advanced age-related macular degeneration or retinitis pigmentosa.
Not a fit: Patients with early-stage retinal diseases or those whose vision loss is not due to retinal degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore vision in patients with advanced retinal diseases.
How similar studies have performed: Previous studies have shown promising results with retinal progenitor tissue transplants in animal models, indicating potential for success in this approach.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Lyon, David C — University of California-Irvine
- Study coordinator: Lyon, David C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.